GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Levetiracetam

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Historical GlobalRPh table transcription. Verify the exact current product label and whether its creatinine-clearance table is indexed to body surface area before applying it.

Check source scope before reading a dose

Keppra - labeled renal guidance

Product / population
Levetiracetam (Keppra), adult oral immediate-release
Renal method
CrCl normalized to 1.73 m2, mL/min/1.73 m2
Source revision
DailyMed SPL version 36, posted Jan 29, 2026
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Keppra - product and source limitations

Use the labeled table for the other clearance bands. The XR and injection products have separate source records.

What to reconcile: Apply only to the stated formulation, indication and renal population.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references

Roweepra - product and source limitations

Use the renal table for the exact oral product. Confirm the tablet strength and dosing interval.

What to reconcile: Apply only to the stated formulation, indication and renal population.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Keppra - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Levetiracetam (Keppra), adult oral immediate-release

Renal method: CrCl normalized to 1.73 m2, mL/min/1.73 m2
Source date: DailyMed SPL version 36, posted Jan 29, 2026
Retrieved: 2026-11-07

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: 2.5 Dosage Adjustments in Adult Patients with Renal Impairment / 8.6 Renal Impairment

Adult immediate-release oral dosing uses CrCl adjusted to 1.73 m2. The dialysis row gives 500-1,000 mg every 24 hours and an additional 250-500 mg after dialysis. Use the labeled table for the other clearance bands. The XR and injection products have separate source records.

RDM74-keppra-official-1 · Source locator: Renal guidance: 2.5 Dosage Adjustments in Adult Patients with Renal Impairment / 8.6 Renal Impairment

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ca9df05-a506-4ec8-a4fe-320f1219ab21
Retrieved
2026-11-07
Renal-function method
CrCl normalized to 1.73 m2, mL/min/1.73 m2
Source date/version
DailyMed SPL version 36, posted Jan 29, 2026
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
9595303425ca4f3975180a49f888c96c56e77acef583ad87347d0aca7ccdbc71

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=levetiracetam&s1=RDM74-keppra-official&h1=89f3a0ce4110f7611c96a4ecc871b967afe4e9c680fca8b2b1233588e9c4995a

Top